Cite
Van Damme P, Tilkin P, Mercer KJ, et al. Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study. Brain Commun. 2020;2(2):fcaa160doi: 10.1093/braincomms/fcaa160.
Van Damme, P., Tilkin, P., Mercer, K. J., Terryn, J., D'Hondt, A., Herne, N., Tousseyn, T., Claeys, K. G., Thal, D. R., Zachrisson, O., Almqvist, P., Nuttin, B., Jerling, M., Bernadotte, F., Haegerstrand, A., & Robberecht, W. (2020). Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study. Brain communications, 2(2), fcaa160. https://doi.org/10.1093/braincomms/fcaa160
Van Damme, Philip, et al. "Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study." Brain communications vol. 2,2 (2020): fcaa160. doi: https://doi.org/10.1093/braincomms/fcaa160
Van Damme P, Tilkin P, Mercer KJ, Terryn J, D'Hondt A, Herne N, Tousseyn T, Claeys KG, Thal DR, Zachrisson O, Almqvist P, Nuttin B, Jerling M, Bernadotte F, Haegerstrand A, Robberecht W. Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study. Brain Commun. 2020 Sep 29;2(2):fcaa160. doi: 10.1093/braincomms/fcaa160. eCollection 2020. PMID: 33977260; PMCID: PMC8099230.
Copy
Download .nbib